ABSTRACT

Active surveillance (AS) is emerging as an alternative approach to limit the risk of overtreatment and impairment of quality of life (QoL) in patients with low-risk localised prostate cancer. Patients with prostate cancer may be distressed by the idea of living with untreated cancer. However, most of them report high levels of QoL. We aimed to assess quality of life of the patients in AS with low-risk localised prostate cancer.